5% Glucose Injection Non-PVC 250ml

• Application: Internal Medicine
• Usage Mode: IV
• Suitable for: Elderly, Children, Adult
• State: Injection
• Shape: Infusion
• Type: Generic Medicine
• Model NO.: 250ml BAG
• Pharmaceutical Technology: Chemical Synthesis
• Drug Reg./Approval No.: H13022474
• Production Line: GMP Approved
• Specification: 250ml: 12.5g
• Trademark: SHIMEN
• Origin: China
• HS Code: 3004909099
• Production Capacity: 230000/Month

Product Description

Glucose 5% Intravenous Infusio
Product Name: Glucose 5% Intravenous Infusion
Main ingredients and chemical name: Glucose
Structural formula:
 

Molecular formula : C₆H₁₂O₆·H₂O
Molecular weight: 198.17
CharacterThe product is a colorless, or almost colorless clear liquid, with sweet flavor.
Indications
(1)Used for supplement of energy and body liquid; used for the scarcity of feeding and body liquid caused by all cases  (such as vomiting, diarrhea ), intravenous hyperalimentation,ketosis;
(2)hypoglycaemia;
(3)hyperpotassemia;
(4)Hypertonic solution could be used as dehydrant for body tissue.;
(5)Used for the preparation of peritoneum dialyszte;
(6)Used as medicine diluent;
(7)Used for the test of dosis tolerate of glucose administered by phleboclysis;
(8)Used for the preparation of GIK.
Dosage and administration
(1)Heat supplement: When the patients take little food or even can not take food for some causes, 25% glucose injection can be administered by phleboclysis, as well as the body fluid was supplied. The dose can be estimated according to the heat energy on demand.
(2)Intravenous hyperalimentation treatment: Glucose is one of the most important energy material when used with this method. For the non-protein heat, the proportion of the heat supplied by glucose and fat is 2:1, and the clinical dosage should be estimated according to the heat supplement on demand. As per the requirement of liquid supplement, the glucose can be prepared to get the injection with the different concentration ranged 25~50%, and the some drug can be added from necessity, the quantity of some drug is 1 unit vs 5~10g. Since the administration of high-concentration glucose solution is irritative for the vein, at the same time adipose emulsion should be used, the large vein is usually elected to drip by intravenous.
(3)For hypoglycemia, 50% glucose injection with the dose 20~40ml may be administered by mainline for the serious firstly.
(4)For ketosis, 5~25% glucose injection is administered by drip for the serious and 100g daily can control the disease.
(5)For the isotonia dehydration, 5% glucose injection can be administered by drip.
(6)For hyperpotassemia, 10~25% glucose injection, and every 2~4g glucose combined with 1 unit some drug is administered by drip can reduce the concentration of serum potassium. But this method only lead to the potassium from outside cell to the inner, and the total potassium in body remain unchangeable.  If any actions are not taken  to excrete the potassium, there still exists the possibility of hyperpotassemia.
(7)For tissue dehydration, high-concentration glucose injection (usually 50% glucose injection) should be administered fleetly by intravenous injection with the dose 20~50ml, but the effect may be very temporary. And during the clinical usage hyperglycemia should be avoided, and this method is seldom used at present. When used for the adjustment of osmosis pressure of peritoneum dialyszte, 50% glucose injection with the dose 20ml can make the osmosis pressure 1L increase 55mOsm/kgH2O.
Side-effect 
(1)Phlebitis may happen when high-concentration glucose injection was administered by drip, but the occurrence  rate will decrease when administered to the large vein.
(2)Exosmosis of high-concentration glucose injection may lead to locality  gall.
(3)Reactive hypoglycemia: when administered combined with some drug with overdose, reactive hypoglycemia may happen for the patients with original hypoglycemia tendency and when intravenous hyperalimentation treatment was ceased suddenly.
(4)Hyperglycemia non-ketosis coma: It is usually happen when the high-concentration was administered or intravenous hyperalimentation treatment was used for the patients who with the diabetes, stress condition, with the treatment of high-dose glucocorticoid, or for the patients who received peritoneal dialysis for the treatment of toxuria.
(5)Electrolyte disturbance: Glucose is administered singly for long term may lead to hypo-potassium, hypo-sodium, and hypophosphatemia.
(6)Original cardiac functional insufficiency;
(7)Hyperpotassemia ,the cases may happen occasionally when the patients with I diabetes is administered with high concentration glucose injection.
Contraindication
(1)diabetes ketosis acidose;
(2)hyperglycemia non-ketosis hyperosmotic state;

Manufacturer
    Name:Shijiazhuang No.4 Pharmaceutical Co., Ltd.